Searchable abstracts of presentations at key conferences in endocrinology

ea0029p78 | Adrenal cortex | ICEECE2012

An open, multi-centre, phase IIIB, long term follow-up study to assess the safety, tolerability and efficacy of once-daily oral dual-release hydrocortisone in patients with adrenal insufficiency

Johannsson G. , Nilsson A. , Bergthorsdottir R. , Burman P. , Dahlqvist P. , Ekman B. , Eden Engstrom B. , Ragnarsson O. , Ryberg M. , Wahlberg J. , Skrtic S.

Introduction: There are limited prospective safety data on glucocorticoid replacement. The aim of this study was to assess the safety and efficacy during long term treatment using a once-daily oral dual-release hydrocortisone in patients with adrenal insufficiency (AI).Methods: This is an open, multi-centre study in 71 patients with AI. Most patients were recruited from a previous controlled trial (n=53) where they had received the dual-release th...